City
Epaper

2 arthritis drugs show different results in Covid-19 trials

By IANS | Updated: April 28, 2020 22:25 IST

With different approaches to treating Covid-19 patients being tried, varying results of two different arthritis drug trials on patients have further complicated the search for a cure.

Open in App
inhibitor tocilizumab rapidly reduced fever and improved oxygenation in severe patients, allowing for successful hospital discharge.

gb/arm

( With inputs from IANS )

Open in App

Related Stories

InternationalBRICS can "shape a new, sustainable framework for global growth," says Oreshkin

Entertainment"Will be remembered for his cinematic brilliance, versatility": PM Modi pays tribute to Kota Srinivas Rao

InternationalBalochistan will never be Pakistan: Baloch leader Qazi Rehan on launch of 'Operation Baam'

InternationalMoS Margherita holds talks with New Zealand FM at East Asia Summit Foreign Ministers' Meeting

CricketShoaib Bashir expected to bowl in fourth innings of Lord's Test after sustaining finger injury

Health Realted Stories

HealthStudy reveals hidden heart risks in women with Type 2 Diabetes

HealthSugar & oil boards in govt offices, schools ‘excellent step’ for healthy India: Experts

HealthAIIA’s national seminar to explore trends in Ayurvedic surgical practices

HealthIIT Delhi launches MRI research facility to foster innovation in medical imaging

HealthWHO acknowledges India’s efforts in integrating AI in traditional medicine, Ayush